Table 1 Baseline characteristics, induction therapy for kidney transplantation, and immunologic risk factors of the original cohort.

From: Early postoperative urinary MCP-1 as a potential biomarker predicting acute rejection in living donor kidney transplantation: a prospective cohort study

 

Total (n = 77)

Control (n = 42)

AR (n = 35)

P value

Age, mean (SD) (years)

42.4 (12.9)

42.0 (13.7)

44.1 (11.9)

0.292

Male, number (%)

52 (67.5)

26 (61.9)

26 (74.3)

0.248

Cause of ESKD, number (%)

   

0.038

Diabetes mellitus

19 (24.7)

9 (24.7)

10 (27.8)

0.469

Hypertension

5 (6.5)

5 (12.2)

0 (0)

0.059

Glomerulonephritis

29 (36.7)

17 (41.5)

12 (33.3)

0.577

Others

10 (13.0)

2 (4.9)

8 (11.1)

0.037

Unknown

14 (18.2)

9 (21.9)

5 (13.9)

0.418

Induction therapy, number (%)

   

0.250

Steroid only

4 (5.2)

3 (7.1)

1 (2.9)

 

Basiliximab and steroid

62 (80.5)

33 (78.6)

29 (82.9)

 

ATG and steroid

11 (14.3)

6 (14.3)

5 (14.3)

 

ABO-incompatible KT, number (%)

4 (5.2)

1 (2.4)

3 (8.6)

0.325

PRA, class I (+), number (%)

15 (19.5)

10 (23.8)

5 (14.2)

> 0.999

% in patients with PRA, class I

 

41.1 ± 29.24

25.4 ± 21.93

 

PRA, class II (+), number (%)

22 (28.6)

14 (33.3)

8 (22.9)

> 0.999

% in patients with PRA, class II

 

24.4 ± 31.67

33.2 ± 37.98

 

DSA (+), number (%)

6 (7.8)

3 (7.1)

3 (8.6)

> 0.999

  1. Continuous variables are expressed as mean (standard deviation) and categorical variables are expressed as number (percentage).
  2. Others for cause of ESKD included autosomal dominant polycystic kidney disease, lupus nephritis, obstructive nephropathy, and Alport syndrome.
  3. % in patients with PRA: mean ± standard deviation.
  4. AR acute rejection, ATG anti-thymocyte globulin, DSA donor specific antibodies, ESKD end-stage kidney disease, KT kidney transplantation, PRA panel reactive antibodies, SD standard deviation.
Back to article page